Jones Financial Companies
CYTK icon

Jones Financial Companies’s Cytokinetics CYTK Stock Holding History

Jones Financial Companies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
26,593
+17,402
+189% +$1.25M ﹤0.01% 1535
2026
Q1 		$574K Buy
9,191
+6,961
+312% +$442K ﹤0.01% 1974
2025
Q4 		$142K Buy
2,230
+372
+20% +$23.1K ﹤0.01% 2071
2025
Q3 		$93.6K Buy
1,858
+1,017
+121% +$41.9K ﹤0.01% 2110
2025
Q2 		$27.9K Buy
841
+102
+14% +$3.55K ﹤0.01% 2457
2025
Q1 		$31.9K Buy
739
+168
+29% +$7.72K ﹤0.01% 2235
2024
Q4 		$26.9K Buy
571
+374
+190% +$19.4K ﹤0.01% 2125
2024
Q3 		$10.3K Sell
197
-287
-59% -$16K ﹤0.01% 2200
2024
Q2 		$26.2K Buy
+484
New +$29.2K ﹤0.01% 1465

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's CYTK Position: Q2 2026 in Review

Jones Financial Companies increased its Cytokinetics (CYTK) stake by 189% in Q2 2026, buying an estimated $1.25M and bringing the position to 26,593 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Jones Financial Companies first reported a position in CYTK in Q2 2024 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Jones Financial Companies held 26,593 shares of Cytokinetics worth $2.19M as of Q2 2026.
  • Jones Financial Companies bought 17,402 Cytokinetics shares in Q2 2026, an estimated $1.25M.
  • Cytokinetics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1535 holding.
  • Jones Financial Companies first reported a position in Cytokinetics in Q2 2024 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.